Back
ACVC Premium Access

Influence of bleeding and ischemic risk on the prescription of new antiplatelets in patients with acute coronary syndrome

Session: Poster Session 1 - Antithrombotic therapy
Topic: Antithrombotic agents
Speaker: Miss M. Sanchez (Orihuela, ES)
Event: Acute Cardiovascular Care 2016

Congress Presentation

Add to my library

Like

About the speaker

Miss Maria Josefa Sanchez

Vega Baja Hospital in Orihuela, Orihuela (Spain)
0 follower

9 more presentations in this session

Antiplatelet therapy in code STEMI: who, when and where?

Access
Like
Thumbnail

Anticoagulant switch in non-ST elevation acute myocardial infarction: prevalence and impact in in-hospital morbidity and mortality

Speaker: Doctor B. Picarra (Evora, PT)

Access
Abstract
Like
Thumbnail

Dual antiplatelet therapy in Russian patients beyond 12 months after myocardial infarction (EPICOR-RUS study)

Speaker: Doctor Y. Khomitskaya (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and appropriateness of antiplatelet therapy in acute coronary syndromes: a single centre real world experience.

Speaker: Doctor B. Musumeci (Rome, IT)

Access
Abstract
Like
Thumbnail

Use of new antiplatelet drugs in elderly patients with acute coronary syndrome in the real world.

Speaker: Doctor L. Madrona Jimenez (Seville, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Antithrombotic therapy

Speakers: Miss M. Sanchez, Doctor B. Picarra, Doctor Y. Khomitskaya, Doctor B. Musumeci, Doctor L. Madrona Jimenez
Access
Like
Thumbnail

About the event

Image

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources